Sentiment Trading

CureVac NV has received a positive patent decision from the European Patent Office, dismissing opposition from BioNTech SE and others, in a significant development in their ongoing legal dispute.

CureVac NV has received a favorable decision from the European Patent Office, dismissing opposition to its patent and potentially boosting its market position and financial performance.